Weight-loss drug before surgery to aid weight loss
Part of Hormones & metabolism clinical trials.
This trial tests whether taking a weight-loss medication (liraglutide) together with standard dietary advice before weight-loss surgery helps more than dietary advice alone. If you're planning such surgery, this could help you lose more weight beforehand, which might make surgery safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must weigh enough to have a body mass index (BMI) above 35 — in other words, you have severe obesity.
- You are already planning to have weight-loss (bariatric) surgery.
- You have health insurance through the Austrian Health Insurance Fund (Österreichische Gesundheitskasse)
- You are willing to be assigned to either group — taking the weight-loss drug liraglutide or only following dietary advice.
- You agree to follow the recommended diet plan before surgery.
- You are willing to attend follow-up visits that include blood tests and body weight measurements with a special scale.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether bariatric surgery or the drug liraglutide helps people with obesity lose weight and keep it off by looking at how it affects your thinking and behavior. It might help you understand which treatment works best for long-term success.
This trial tests whether taking a weekly injection called semaglutide (a type of medicine used for weight loss) for about 16 weeks before weight-loss surgery can help people with a very high BMI prepare for surgery. It may reduce liver fat and make surgery safer, which could lead to better outcomes.
This study tests whether taking semaglutide (a once-weekly injection that helps control appetite and blood sugar) before and after a second weight-loss surgery can help people who regained weight after an initial sleeve gastrectomy. The goal is to see if the medicine improves weight-loss outcomes compared to surgery alone.
This study compares two weight-loss medicines: liraglutide (a daily injection) and orlistat (a pill), given alone or together, over 24 weeks. It aims to see which approach is safer and works better for people who are overweight or have obesity.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
This trial is for people who had metabolic surgery 6 months ago and still have a BMI of 28 or higher. It tests whether an anti-obesity medication can help with further weight loss after surgery.
Hear when a new Obesity, Adolescent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.